You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ruxolitinib Cream

Showing 26 - 50 of 1,534
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-segmental Vitiligo Trial in Worldwide (Ruxolitinib cream, Vehicle)

Completed
  • Non-segmental Vitiligo
  • Hoover, Alabama
  • +56 more
Mar 8, 2022

Atopic Dermatitis Trial in Worldwide (Ruxolitinib Cream, Vehicle Cream)

Completed
Has Results
  • Atopic Dermatitis
  • Ruxolitinib Cream
  • Vehicle Cream
  • Birmingham, Alabama
  • +78 more
Nov 19, 2021

Atopic Dermatitis Trial in Canada, United States (Ruxolitinib, Vehicle Cream)

Recruiting
  • Atopic Dermatitis
  • Birmingham, Alabama
  • +90 more
Dec 1, 2022

Non-segmental Vitiligo Trial in Worldwide (Ruxolitinib cream, Vehicle)

Completed
  • Non-segmental Vitiligo
  • Gilbert, Arizona
  • +75 more
Mar 8, 2022

Vitiligo Trial in United States (Ruxolitinib cream, Vehicle cream)

Completed
Has Results
  • Vitiligo
  • Ruxolitinib cream
  • Vehicle cream
  • Birmingham, Alabama
  • +25 more
Dec 8, 2021

Alopecia Areata Trial in United States (Placebo Cream, Ruxolitinib Phosphate Cream)

Terminated
Has Results
  • Alopecia Areata
  • Placebo Cream
  • Ruxolitinib Phosphate Cream
  • Birmingham, Alabama
  • +17 more
Nov 20, 2020

Vitiligo Trial in Nice (Ruxolitinib Topical, Placebo)

Not yet recruiting
  • Vitiligo
  • Ruxolitinib Topical
  • Placebo
  • Nice, Alpes-maritimes, France
    CHU de Nice - Hôpital de l'Archet
May 22, 2023

Vitiligo Trial in Boston (Ruxolitinib 1.5% Phosphate Cream)

Completed
Has Results
  • Vitiligo
  • Ruxolitinib 1.5% Phosphate Cream
  • Boston, Massachusetts
    Tufts Medical Center
Aug 21, 2020

Atopic Dermatitis Trial in Canada, United States (Ruxolitinib 0.15% Cream QD, Ruxolitinib 0.5% Cream QD, Ruxolitinib 1.5% Cream

Completed
Has Results
  • Atopic Dermatitis
  • Ruxolitinib 0.15% Cream QD
  • +5 more
  • Birmingham, Alabama
  • +51 more
Mar 16, 2021

Atopic Dermatitis Trial in Canada, United States (Ruxolitinib cream)

Completed
  • Atopic Dermatitis
  • Ruxolitinib cream
  • Anaheim, California
  • +9 more
Feb 12, 2020

Atopic Dermatitis Trial in United States (Ruxolitinib phosphate cream)

Completed
  • Atopic Dermatitis
  • Ruxolitinib phosphate cream
  • Hoover, Alabama
  • +22 more
Nov 9, 2020

Chronic Hand Dermatitis Trial in Rochester (Ruxolitinib)

Recruiting
  • Chronic Hand Dermatitis
  • Rochester, New York
    UR Medicine Dermatology College Town
Aug 9, 2022

Psoriasis Trial in United States (Ruxolitinib)

Completed
Has Results
  • Psoriasis
  • Fridley, Minnesota
  • +3 more
Feb 4, 2022

Lichen Planus Trial in Scottsdale (INCB018424)

Completed
Has Results
  • Lichen Planus
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Aug 2, 2021

Vitiligo, Generalized Trial (Baricitinib)

Not yet recruiting
  • Vitiligo, Generalized
  • (no location specified)
Jul 7, 2023

GVHD, Acute Stem Cell Transplant Complications Trial in Chendu (Ruxolitinib)

Not yet recruiting
  • GVHD
  • Acute Stem Cell Transplant Complications
  • Chendu, Sichuan, China
    West China Hospital, Sichuan University
Oct 3, 2023

Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera

Completed
  • Adherence, Patient
  • Adherence, Treatment
    • Cosenza, Calabria, Italy
    • +27 more
    Oct 11, 2023

    Metastatic Triple-Negative Breast Carcinoma, Breast Cancer Trial in Dallas (Neratinib Oral Tablet, Ruxolitinib Oral Tablet)

    Not yet recruiting
    • Metastatic Triple-Negative Breast Carcinoma
    • Breast Cancer
    • Neratinib Oral Tablet
    • Ruxolitinib Oral Tablet
    • Dallas, Texas
      Baylor University Medical Center, Baylor Charles A Sammons Cance
    Aug 22, 2023

    Hemophagocytic Lymphohistiocytosis Trial in United States (Ruxolitinib, Dexamethasone, Etoposide)

    Recruiting
    • Hemophagocytic Lymphohistiocytosis
    • Phoenix, Arizona
    • +9 more
    Jan 9, 2023

    Myelofibrosis Trial in Worldwide (BMS-986158, Ruxolitinib, Fedratinib)

    Recruiting
    • Myelofibrosis
    • La Jolla, California
    • +36 more
    Jan 13, 2023

    Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

    Recruiting
    • Myelofibrosis
    • +3 more
    • Berkeley, California
    • +176 more
    Dec 1, 2022

    Myeloproliferative Tumor Trial in Worldwide (Navitoclax, Ruxolitinib, Celecoxib)

    Recruiting
    • Myeloproliferative Neoplasm
    • Duarte, California
    • +41 more
    Feb 1, 2023

    Lymphoma Trial in United States (Ruxolitinib)

    Recruiting
    • Lymphoma
    • Miami, Florida
    • +9 more
    Oct 5, 2022

    Multiple Myeloma Trial in Detroit, Charlotte (Carfilzomib, Ruxolitinib, Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Detroit, Michigan
    • +1 more
    Jan 27, 2023

    T-Cell Large Granular Lymphocyte Leukemia Trial in Columbus (Ruxolitinib)

    Not yet recruiting
    • T-Cell Large Granular Lymphocyte Leukemia
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Oct 20, 2022